+28.2%
MRNA vs FE
+46.9%
-18.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.5% | -2.8% | -3.3% |
| 7D | -10.1% | -0.2% | -9.9% | -10.1% |
| 30D | +126.7% | -1.2% | +127.9% | +126.9% |
| 3M | +184.1% | +1.7% | +182.5% | +182.7% |
| 6M | +143.3% | -7.5% | +150.8% | +146.2% |
| YTD | +359.9% | +6.3% | +353.5% | +355.4% |
| 1Y | +454.2% | +10.9% | +443.3% | +448.5% |
| All | +28.2% | +46.9% | -18.7% | +13.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FE.
Daily Out/Under-Performance
Portfolio return minus FE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling